Clinical Trials Browser

Pathologic Complete Response, Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Advanced NUT Carcinoma

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Lung Neoplasms, Small Cell Lung Carcinoma

Carcinoma, Non-Small-Cell Lung

Advanced Solid Tumors

Advanced Biliary Tract Carcinoma

Bone Neoplasms, Sarcoma, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Carcinoma, Non-Small-Cell Lung

Biliary Tract Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Biliary Tract Neoplasms

Brain Neoplasms, Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Advanced Cancer

Ovarian Neoplasms, Uterine Neoplasms

Nasopharyngeal Carcinoma, Recurrence

Advanced Solid Tumor

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Esophageal Cancer TNM Staging Primary Tumor (T) T4

Cervical Adenocarcinoma

Uterine Cervical Neoplasms, Recurrence

Squamous Cell Carcinoma of Head and Neck

Advanced Intrahepatic Cholangiocarcinoma

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases, Mouth Neoplasms, Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Esophageal Neoplasms

Carcinoma, Neuroendocrine

Locally Advanced Cervical Carcinoma

Uterine Cervical Neoplasms

Esophageal Squamous Cell Carcinoma

Clinical Trials

Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

KRAScendo 170

Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT Carcinoma

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma

Safety and Tolerability of LDRT+Sugemalimab+Chemotherapy+Olaparib for First-Line Treatment of SLFN-11 Positive ES-SCLC

ALTAIR

A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors

Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer

Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

A Phase Ib/II Study of 7MW3711 Combined With JS207 in Advanced Solid Tumors

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)

MK-9999-02A

Acclaim-1

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

SOLARA

A Trial of SHR-A2102 With Adebrelimab With or Without Other Antitumor Therapy in Advanced or Metastatic Non-small Cell Lung Cancer

A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Establishing Best Treatment Strategy for T4 Esophageal Cancer

External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer

SHR-A1811 Combination Regimen for the Treatment of Recurrent or Metastatic Cervical Cancer

AK129 Combination Therapy for Advanced Solid Tumors

Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma

RADIAN

Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC

Chemoradiotherapy in Unresectable Esophageal Cancer

Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma

Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer